Enalapril liquid - Proveca
Latest Information Update: 30 Aug 2016
At a glance
- Originator Proveca
- Class Antihypertensives; Heart failure therapies; Small molecules
- Mechanism of Action ACE inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Acute heart failure
Most Recent Events
- 15 Mar 2016 Biomarkers information updated